FOXP3 and nasopharyngeal carcinoma: Our finding that the combination of Foxp3+TIL and GrB+TIL (activated CTL) was an independent favorable factor and was significantly associated with improved outcomes of OS and PFS in the patients with late-stage disease further support the assumption of the favorable role of Treg in NPC patients.